CDC Gives Final Approval to Omicron COVID-19 Vaccine Boosters
CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, CDC director follows suit.
CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, CDC director follows suit.